# EDGAR Filing Document

**Accession Number:** 0000910267
**File Stem:** 0001641172-25-020611
**Filing Date:** 2025-7
**Character Count:** 2214
**Document Hash:** e32af605004cf122bfdc87b0c21aeaca
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-020611.hdr.sgml**: 20250722

**ACCESSION NUMBER**: 0001641172-25-020611

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20250722

**DATE AS OF CHANGE**: 20250722

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TITAN PHARMACEUTICALS INC
- **CENTRAL INDEX KEY:** 0000910267
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 943171940
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13341
- **FILM NUMBER:** 251140927

**BUSINESS ADDRESS:**
- **STREET 1:** 400 OYSTER POINT BLVD
- **STREET 2:** SUITE 505
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** 6502444990

**MAIL ADDRESS:**
- **STREET 1:** 400 OYSTER POINT BLVD
- **STREET 2:** SUITE 505
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 14A**

**(Rule 14a-101)**

**INFORMATION REQUIRED IN PROXY STATEMENT**

**SCHEDULE 14A INFORMATION**

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No.)

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ Definitive
 Additional Materials

☐ Soliciting Material under §240.14a-12

---

| |
|:---|
| **Titan Pharmaceuticals, Inc.** |
| (Name of Registrant as Specified In Its Charter) |
| (Name of Persons(s) Filing Proxy Statement, if other than the Registrant) |

---

Payment of Filing Fee (Check all boxes that apply):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ No
 fee required

☐ Fee paid previously with preliminary materials

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

![](proxy_001.jpg)

![](proxy_002.jpg)